Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma
暂无分享，去创建一个
R. Motzer | T. Powles | T. Choueiri | S. Park | B. Escudier | D. George | C. Kollmannsberger | S. Pal | S. Rha | E. Grande | C. Suarez | H. Gurney | P. Geertsen | J. Pikiel | D. Markby | A. Arroyo | Mark Dean | M. Gross‐Goupil